Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:933-938 (22 April), doi:10.1136/bmj.332.7547.933
Doris Staab, paediatric allergologist1, Thomas L Diepgen, professor2, Manigé Fartasch, professor3, Jörg Kupfer, psychologis4, Thomas Lob-Corzilius, paediatric allergologist5, Johannes Ring, professor6, Sibylle Scheewe, paediatric allergologist7, Reginald Scheidt, epidemiologist2, Gerhard Schmid-Ott, professor8, Christina Schnopp, dermatologist6, Rüdiger Szczepanski, paediatric allergologist5, Thomas Werfel, professor9, Marita Wittenmeier, atopic dermatitis trainer10, Ulrich Wahn, professor1, Uwe Gieler, professor11
1 Department of Paediatric Pulmonology and Immunology, Charité, Humboldt University, Berlin, 2 Department of Clinical Social Medicine, Occupational and Environmental Dermatology, University Hospital Heidelberg, Thibautstrasse 3, D-69115 Heidelberg, Germany, 3 Department of Dermatology, University Erlangen, Germany, 4 Department for Medical Psychology, Justus-Liebig-University Giessen, Germany, 5 Childrens Hospital Osnabrück, Germany, 6 Department of Dermatology and Allergy Biederstein, Technical University Munich, Germany, 7 Rehabilitation Clinic for Children and Adolescents, Sylt, Germany, 8 Department of Psychosomatic Medicine, Hannover Medical School, Germany, 9 Department of Dermatology and Allergology, Hannover Medical School, Germany, 10 Childrens' Hospital Amsterdamer Strasse, Köln, Germany, 11 Department of Psychosomatic Medicine and Psychotherapy, Justus-Liebig-University Giessen, Germany
Correspondence to: T L Diepgen thomas_diepgen{at}med.uni-heidelberg.de
Objective To determine the effects of age related, structured educational programmes on the management of moderate to severe atopic dermatitis in childhood and adolescence.
Design Multicentre, randomised controlled trial.
Setting Seven hospitals in Germany.
Participants Parents of children with atopic dermatitis aged 3 months to 7 years (n = 274) and 8-12 years (n = 102), adolescents with atopic dermatitis aged 13-18 years (n = 70), and controls (n = 244, n = 83, and n = 50, respectively).
Interventions Group sessions of standardised intervention programmes for atopic dermatitis once weekly for six weeks or no education (control group).
Main outcome measures Severity of eczema (scoring of atopic dermatitis scale), subjective severity (standardised questionnaires), and quality of life for parents of affected children aged less than 13 years, over 12 months.
Results Significant improvements in severity of eczema and subjective severity were seen in all intervention groups compared with control groups (total score for severity: age 3 months to 7 years - 17.5, 95% confidence intervals - 19.6 to - 15.3 v - 12.2, - 14.3 to - 10.1; age 8-12 years - 16.0, - 20.0 to - 12.0 v - 7.8, - 11.4; - 4.3; and age 13-18 years - 19.7, - 23.7 to - 15.7 v - 5.2, - 10.5 to 0.1). Parents of affected children aged less than 7 years experienced significantly better improvement in all five quality of life subscales, whereas parents of affected children aged 8-12 years experienced significantly better improvement in three of five quality of life subscales. Conclusion Age related educational programmes for the control of atopic dermatitis in children and adolescents are effective in the long term management of the disease.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
which ones work? Meta-analysis of published reports
Read all Rapid Responses